Literature DB >> 3527827

Growth-promoting effects of diabetes and insulin on arteries. An in vivo study of rat aorta.

L Capron, J Jarnet, S Kazandjian, E Housset.   

Abstract

Proliferation of arterial smooth muscle cells is regarded as an important event in atherogenesis, which according to in vitro culture studies is influenced by diabetes and insulin. To assess whether this holds true in vivo, we studied the cellular kinetics of thoracic aorta in normal and streptozocin-induced diabetic rats with and without insulin treatment. We measured the incorporation of [3H]thymidine into intima-media, as well as its DNA content, 2 and 14 days after endothelial denudation. We found that the mitotic response of an injured artery is not modified by diabetes but is depressed by insulin treatment in nondiabetic rats, probably due to hypoglycemia. Our data in insulin-treated diabetic rats support but do not definitely settle the view that insulin is mitogenic as long as the treatment does not cause sustained hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3527827     DOI: 10.2337/diab.35.9.973

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

Review 1.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

2.  Insulin resistance and risk of incident hypertension among men.

Authors:  Tai-Shuan Lai; Gary C Curhan; John P Forman
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-09       Impact factor: 3.738

Review 3.  Endothelial function. General considerations.

Authors:  H Haller
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 4.  Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies.

Authors:  Christina Voulgari; Dimitrios Papadogiannis; Nicholas Tentolouris
Journal:  Vasc Health Risk Manag       Date:  2010-10-21

5.  Absence of clinically overt atherosclerotic vascular disease and adverse changes in cardiovascular risk factors in 70 patients with insulinoma.

Authors:  F Leonetti; P Iozzo; A Giaccari; P Sbraccia; A Buongiorno; G Tamburrano; D Andreani
Journal:  J Endocrinol Invest       Date:  1993-12       Impact factor: 4.256

Review 6.  The link between insulin resistance and hypertension. Effects of antihypertensive and antihyperlipidaemic drugs on insulin sensitivity.

Authors:  T Baba; S Neugebauer
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

7.  In vivo proliferation of rat vascular smooth muscle in relation to diabetes mellitus insulin-like growth factor I and insulin.

Authors:  K E Bornfeldt; H J Arnqvist; L Capron
Journal:  Diabetologia       Date:  1992-02       Impact factor: 10.122

8.  Selective loss of vascular smooth muscle cells in the retinal microcirculation of diabetic dogs.

Authors:  T A Gardiner; A W Stitt; H R Anderson; D B Archer
Journal:  Br J Ophthalmol       Date:  1994-01       Impact factor: 4.638

Review 9.  Ulster says 'NO'; explosion, resistance and tolerance. Nitric oxide and the actions of organic nitrates.

Authors:  G D Johnston
Journal:  Ulster Med J       Date:  1998-11

10.  Short-Term Therapy with Rosiglitazone, a PPAR-γ Agonist, Improves Metabolic Profile and Vascular Function in Nonobese Lean Wistar Rats.

Authors:  Mohammad M Naderali; Imose Itua; Abdul-Razak Abubakari; Ebrahim K Naderali
Journal:  ISRN Pharmacol       Date:  2012-08-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.